Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study

Thrombosis Research

Volumn 132, Issue 1, 2013, Pages

  Zuily, Stéphane ^a,b,c   Regnault, Véronique ^a,b,c   Guillemin, Francis ^a,c,d   Kaminsky, Pierre ^a,c   Rat, Anne Christine ^a,c,d   Lecompte, Thomas ^a,b,c   Wahl, Denis ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM UMR S 1116 University of Lorraine   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d INSERM   (France)

Author keywords

Activated Protein C resistance; Antiphospholipid antibodies; Superficial vein thrombosis; Systemic lupus erythematosus; Thrombin generation

Indexed keywords

THROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUPERFICIAL VEIN THROMBOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; VEIN THROMBOSIS;

ACR; ACTIVATED PROTEIN C; ACTIVATED PROTEIN C RESISTANCE; ACTIVATED PROTEIN C SENSITIVITY RATIO; AMERICAN COLLEGE OF RHEUMATOLOGY; ANTIPHOSPHOLIPID ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; APC; APCSR; APL; APS; CALIBRATED AUTOMATED THROMBOGRAPHY; CAT; CI; COMPUTED TOMOGRAPHY; CONFIDENCE INTERVAL; CT; DEEP VEIN THROMBOSIS; DVT; ELISA; ENDOGENOUS THROMBIN POTENTIAL; ENZYME LINKED IMMUNOSORBENT ASSAYS; ETP; GLYCOPROTEIN I; HAZARD RATIO; HR; INTER QUARTILE RANGE; INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS; IQR; ISTH; LR+; LR-; NEGATIVE LIKELIHOOD RATIO; NEGATIVE PREDICTIVE VALUE; NPV; POSITIVE LIKELIHOOD RATIO; POSITIVE PREDICTIVE VALUE; PPV; SLE; SS(2)GPI; SUPERFICIAL VEIN THROMBOSIS; SVT; SYSTEMIC LUPUS ERYTHEMATOSUS; TG; THROMBIN GENERATION; THROMBOTIC ISCHEMIC ATTACKS; TIAS; VITAMIN K ANTAGONISTS; VKAS;

ACTIVATED PROTEIN C RESISTANCE; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; RISK FACTORS; THROMBIN; VENOUS THROMBOSIS;

EID: 84881313977     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.012     Document Type: Article

References (52)

1. K.S. Ginsburg, M.H. Liang, L. Newcomer, S.Z. Goldhaber, P.H. Schur, and C.H. Hennekens Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis Ann Intern Med 117 1992 997 1002
2. D.G. Wahl, F. Guillemin, E. de Maistre, C. Perret, T. Lecompte, and G. Thibaut Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis Lupus 6 1997 467 473 (Pubitemid 27395386)
3. D.G. Wahl, F. Guillemin, E. de Maistre, C. Perret-Guillaume, T. Lecompte, and G. Thibaut Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis Lupus 7 1998 15 22 (Pubitemid 28052657)
4. M.K. Farmer-Boatwright, and R.A. Roubey Venous thrombosis in the antiphospholipid syndrome Arterioscler Thromb Vasc Biol 29 2009 321 325
5. R.H. Derksen, M.A. Khamashta, and D.W. Branch Management of the obstetric antiphospholipid syndrome Arthritis Rheum 50 2004 1028 1039 (Pubitemid 38480813)
6. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
7. D. Erkan, and M.D. Lockshin Non-criteria manifestations of antiphospholipid syndrome Lupus 19 2010 424 427
8. S. Zuily, V. Regnault, C. Selton-Suty, V. Eschwege, J.F. Bruntz, and E. Bode-Dotto Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies Circulation 124 2011 215 224
9. R. Cervera, M.A. Khamashta, Y. Shoenfeld, M.T. Camps, S. Jacobsen, and E. Kiss Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients Ann Rheum Dis 68 2009 1428 1432
10. B. Giannakopoulos, and S.A. Krilis The pathogenesis of the antiphospholipid syndrome N Engl J Med 368 11 2013 1033 1044
11. M.H. Rosove, and P.M. Brewer Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients Ann Intern Med 117 1992 303 308
12. P. de Moerloose, R. Wutschert, M. Heinzmann, T. Perneger, G. Reber, and H. Bounameaux Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight Thromb Haemost 80 1998 239 241 (Pubitemid 28393616)
13. K. van Langevelde, W.M. Lijfering, F.R. Rosendaal, and S.C. Cannegieter Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study Blood 118 2011 4239 4241
14. C.S. Kitchens How I, treat superficial venous thrombosis Blood 117 2011 39 44
15. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 2002 1019 1027 (Pubitemid 34303815)
16. A. Ruffatti, T. Del Ross, M. Ciprian, M. Nuzzo, M. Rampudda, and M.T. Bertero Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study Ann Rheum Dis 68 2009 397 399
17. M.G. Tektonidou, K. Laskari, D.B. Panagiotakos, and H.M. Moutsopoulos Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies Arthritis Rheum 61 2009 29 36
18. K. Devreese, K. Peerlinck, and M.F. Hoylaerts Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants Blood 115 2010 870 878
19. B. de Laat, K. Mertens, and P.G. de Groot Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism Nat Clin Pract Rheumatol 4 2008 192 199
20. K. Sonnevi, S.N. Tchaikovski, M. Holmstrom, J. Rosing, K. Bremme, and G. Larfars Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years Thromb Haemost 106 2011 901 907
21. C. Gardiner, H. Cohen, A. Jenkins, S.J. Machin, and I.J. Mackie Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay Blood Coagul Fibrinolysis 17 2006 477 483 (Pubitemid 44231694)
22. J. Nojima, H. Kuratsune, E. Suehisa, Y. Iwatani, and Y. Kanakura Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism Clin Chem 51 2005 545 552 (Pubitemid 40300230)
23. B. de Laat, C.M. Eckmann, M. van Schagen, A.B. Meijer, K. Mertens, and J.A. van Mourik Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C Blood Coagul Fibrinolysis 19 2008 757 764
24. T. Lecompte, D. Wahl, C. Perret-Guillaume, H.C. Hemker, P. Lacolley, and V. Regnault Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk Haematologica 92 2007 714 715 (Pubitemid 350144283)
25. S. Liestol, P.M. Sandset, M.C. Mowinckel, and F. Wisloff Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants J Thromb Haemost 5 2007 2204 2210 (Pubitemid 47617872)
26. E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, and N.F. Rothfield The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277 (Pubitemid 13221242)
27. M.C. Hochberg Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1997 1725
28. V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, and M. Galli Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis J Thromb Haemost 7 2009 1737 1740
29. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and J.C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 42 1999 1309 1311 (Pubitemid 30265586)
30. R.L. Brey, J. Chapman, S.R. Levine, G. Ruiz-Irastorza, R.H. Derksen, and M. Khamashta Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 Lupus 12 2003 508 513 (Pubitemid 36890141)
31. G. Bertsias, J.P. Ioannidis, J. Boletis, S. Bombardieri, R. Cervera, and C. Dostal EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics Ann Rheum Dis 67 2008 195 205 (Pubitemid 351183308)
32. M. Greaves, H. Cohen, S.J. MacHin, and I. Mackie Guidelines on the investigation and management of the antiphospholipid syndrome Br J Haematol 109 2000 704 715 (Pubitemid 30609746)
33. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb Haemost 74 1995 1185 1190
34. A. Tincani, F. Allegri, M. Sanmarco, M. Cinquini, M. Taglietti, and G. Balestrieri Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum Thromb Haemost 86 2001 575 583 (Pubitemid 32743269)
35. P. De Moerloose, G. Reber, J. Musial, and J. Arnout Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome J Thromb Haemost 8 2010 1540 1546
36. R.T. Urbanus, R.H. Derksen, and P.G. de Groot Platelets and the antiphospholipid syndrome Lupus 17 2008 888 894
37. V. Regnault, S. Beguin, D. Wahl, E. de Maistre, H.C. Hemker, and T. Lecompte Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants Thromb Haemost 89 2003 208 212 (Pubitemid 36227269)
38. A. Membre, D. Wahl, V. Latger-Cannard, J.P. Max, P. Lacolley, and T. Lecompte The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies Haematologica 93 2008 566 573 (Pubitemid 351536385)
39. Subcommittee on Control of Anticoagulation of the SSC of the ISTH Towards a recommendation for the standardization of the measurement of platelet-dependent thrombin generation J Thromb Haemost 9 2011 1859 1861
40. H.C. Hemker, and S. Beguin Phenotyping the clotting system Thromb Haemost 84 2000 747 751
41. H.C. Hemker, P.L. Giesen, M. Ramjee, R. Wagenvoord, and S. Beguin The thrombogram: monitoring thrombin generation in platelet-rich plasma Thromb Haemost 83 2000 589 591 (Pubitemid 30201136)
42. G. Tans, Vlieg A. van Hylckama, M.C. Thomassen, J. Curvers, R.M. Bertina, and J. Rosing Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women Br J Haematol 122 2003 465 470 (Pubitemid 36951632)
43. A.W. de Souza, N.P. Silva, J.F. de Carvalho, V. D'Almeida, M.A. Noguti, and E.I. Sato Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome Lupus 16 2007 782 787 (Pubitemid 350069790)
44. S.M. Toloza, A.G. Uribe, G. McGwin Jr., G.S. Alarcon, B.J. Fessler, and H.M. Bastian Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events Arthritis Rheum 50 2004 3947 3957 (Pubitemid 39643943)
45. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, and G.R. Hughes The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
46. H. Decousus, I. Quere, E. Presles, F. Becker, M.T. Barrellier, and M. Chanut Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study Ann Intern Med 152 2010 218 224
47. M.A. Lucia, and E.W. Ely Images in clinical medicine.Superficial thrombophlebitis N Engl J Med 344 2001 1214
48. A. Danowski, M.N. de Azevedo, J.A. de Souza Papi, and M. Petri Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus J Rheumatol 36 2009 1195 1199
49. P. Prandoni, F. Bilora, A. Marchiori, E. Bernardi, F. Petrobelli, and A.W. Lensing An association between atherosclerosis and venous thrombosis N Engl J Med 348 2003 1435 1441 (Pubitemid 36407172)
50. W. Ageno, C. Becattini, T. Brighton, R. Selby, and P.W. Kamphuisen Cardiovascular risk factors and venous thromboembolism: a meta-analysis Circulation 117 2008 93 102 (Pubitemid 350301144)
51. N. Hezard, L. Bouaziz-Borgi, M.G. Remy, and P. Nguyen Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency Clin Chem 52 2006 665 670
52. K. Devreese, K. Peerlinck, J. Arnout, and M.F. Hoylaerts Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography Thromb Haemost 101 2009 185 196